235 related articles for article (PubMed ID: 15841634)
41. Imiquimod 5% cream (Aldara) in the treatment of basal cell carcinoma.
Sapijaszko MJ
Skin Therapy Lett; 2005; 10(6):2-5. PubMed ID: 16292452
[TBL] [Abstract][Full Text] [Related]
42. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping.
Sullivan TP; Dearaujo T; Vincek V; Berman B
Dermatol Surg; 2003 Dec; 29(12):1181-6. PubMed ID: 14725659
[TBL] [Abstract][Full Text] [Related]
44. Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma.
Garcia-Martin E; Gil-Arribas LM; Idoipe M; Alfaro J; Pueyo V; Pablo LE; Fernandez FJ
Br J Ophthalmol; 2011 Oct; 95(10):1393-6. PubMed ID: 21242584
[TBL] [Abstract][Full Text] [Related]
45. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
46. Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study.
Butler DF; Parekh PK; Lenis A
Dermatol Surg; 2009 Jan; 35(1):24-9. PubMed ID: 19018814
[TBL] [Abstract][Full Text] [Related]
47. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study.
Geisse JK; Rich P; Pandya A; Gross K; Andres K; Ginkel A; Owens M
J Am Acad Dermatol; 2002 Sep; 47(3):390-8. PubMed ID: 12196749
[TBL] [Abstract][Full Text] [Related]
48. Optical coherence tomography imaging of non-melanoma skin cancer undergoing imiquimod therapy.
Banzhaf CA; Themstrup L; Ring HC; Mogensen M; Jemec GB
Skin Res Technol; 2014 May; 20(2):170-6. PubMed ID: 24103017
[TBL] [Abstract][Full Text] [Related]
49. Imiquimod for superficial and in situ skin malignancy.
Drug Ther Bull; 2009 Oct; 47(10):113-6. PubMed ID: 19809085
[TBL] [Abstract][Full Text] [Related]
50. Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy.
Dixon AJ
Aust Fam Physician; 2005; 34(1-2):49-52. PubMed ID: 15727358
[TBL] [Abstract][Full Text] [Related]
51. Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids.
Prokosch V; Thanos S; Spaniol K; Stupp T
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):121-5. PubMed ID: 20886224
[TBL] [Abstract][Full Text] [Related]
52. The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.
Ozolins M; Williams HC; Armstrong SJ; Bath-Hextall FJ
Trials; 2010 Apr; 11():42. PubMed ID: 20409337
[TBL] [Abstract][Full Text] [Related]
53. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma.
Blasi MA; Giammaria D; Balestrazzi E
Am J Ophthalmol; 2005 Dec; 140(6):1136-9. PubMed ID: 16376667
[TBL] [Abstract][Full Text] [Related]
54. Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application.
Gaitanis G; Nomikos K; Vava E; Alexopoulos EC; Bassukas ID
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1427-31. PubMed ID: 19555364
[TBL] [Abstract][Full Text] [Related]
55. Treatment of an extensive superficial basal cell carcinoma of the face with imiquimod 5% cream.
Micali M; Nasca MR; Musumeci ML
Int J Tissue React; 2005; 27(3):111-4. PubMed ID: 16372477
[TBL] [Abstract][Full Text] [Related]
56. Successful treatment and management of large superficial basal cell carcinomas with topical imiquimod 5% cream: a case series and review.
Lacarrubba F; Potenza MC; Gurgone S; Micali G
J Dermatolog Treat; 2011 Dec; 22(6):353-8. PubMed ID: 21781010
[TBL] [Abstract][Full Text] [Related]
57. Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.
Papadavid E; Stratigos AJ; Falagas ME
Expert Opin Pharmacother; 2007 Aug; 8(11):1743-55. PubMed ID: 17685890
[TBL] [Abstract][Full Text] [Related]
58. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
[TBL] [Abstract][Full Text] [Related]
59. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.
Vun Y; Siller G
Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996
[TBL] [Abstract][Full Text] [Related]
60. [How I treat ... basal cell carcinoma by imiquimod].
Piérard-Franchimont C; Nikkels AF; Paquet P; Quatresooz P; Piérard GE
Rev Med Liege; 2005 Apr; 60(4):207-9. PubMed ID: 15943094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
